Neuland Labs Profit Halved as Sales Slump, Costs Sap Margins

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Neuland Labs Profit Halved as Sales Slump, Costs Sap Margins
Overview

Neuland Laboratories Ltd. reported a stark 60% plunge in net profit for the third quarter, falling to ₹40.6 crore. Revenue slid 10.5% year-on-year to ₹439.7 crore, with EBITDA also declining and margins contracting significantly. The company approved capital expenditure for a new R&D center in Hyderabad.

The sharp earnings contraction stems from a confluence of slowing sales and escalating operational costs. Neuland Laboratories' EBITDA fell 10.5% year-on-year to ₹77.3 crore, while its EBITDA margin compressed by 410 basis points, landing at 17.6% compared to 21.7% in the prior year. This indicates a significant deterioration in profitability at the operational level, suggesting either increased input costs, manufacturing inefficiencies, or pricing pressures.

Capex Amidst Downturn

Despite the current financial headwinds, Neuland Laboratories approved a substantial capital expenditure of ₹189 crore. This investment is earmarked for establishing a new research and development center in Hyderabad. The move signals a long-term strategic vision, prioritizing innovation and future growth pipelines even as near-term financial performance falters. Investors will be watching to see if this R&D push can drive future revenue streams and offset the current sales slowdown.

Shares of Neuland Laboratories closed down 1.30% at ₹13,030 on the National Stock Exchange, reflecting market apprehension regarding the company's immediate financial trajectory.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.